Member Info for oldbutnowisa

100% agree, Wiinnimandala.
When this sinks in to the market, this will move up - not vastly, but looking to the future. Very little risk of this scheme failing and that makes this a 12-24 month near certain moneymaker.

...the weak pound since many of its sales will be for dollars and other currencies. Very undervalued.

If both not thrown out this is minimum 5bagger.

...just now! Only one line (Thought I was hearng things!) but no, it was there and I now expect much better explanation of significance of Single Cell Proteomics on science programmes imminently. YOU heard it here at 7.45 a.m today. Big bagger coming up!!

AGM 4th May.

We all know that this is a big project and need more financing before we see production begin. I fully expect a share con solidation before then but I just want no hitches and to be alive to see it.

Invest some of our proceeds (when they arrive) into a bigger position in LGP.

....cheep! No buyers though!

Someone now bought 5000 at near this top. Wise person. This is tomorrow's rocket!

MMs are shouting 'This needs news!' so if there is anything happening, how about telling in RNS, but I shall be very surprised if they listen to me!

At this price and with GSK's p[peline at present, I cannot believe we have not had at least one bid from anywhere.
Cheap as chips.

I held about yer 1999 for a couple of years before taking a loss and only came back for more about 18 mths ago. Immediate year looks promising, but I am the patient sort!

...but no doubt speccies wantd better.

...the number and quality of potential new drugs marching through the Drug Authorities worldwide at present, these have to remain a much maligned quality co due for a serious rerating. Definitely staying in my p/f.

Sadly, you are right but I look on the bright side to keep myself cheerful

...at 8.41p and that is conservative if a single one of their two drugs moves on with the FDA!

With not one but TWO EXCITING new possible drugs at FDA, Sure they are cash-strapped and are some way from earning from them but they have to be valued at multiples of this SP.

The direction is UP, roger65, because in spite of the long term borrowings, this is now making money and is close to offering a very exciting Single Cell Protemics Service to the profession. Look at the figure in the Accounts which covers IP. It has not revalued this for many years. My belief is that this is where a huge amount of value is and the lender knows this. I may be wrong but I believe this is going to move upwards as the potential is more widely recognised.

....trading announcement. Was one 7th April 2022.

My 75000 extra now showing.